Flagellin-Induced Antiviral Activity
Flagellin-Induced Antiviral Activity
批准号:
8655677
负责人:
Andrew T Gewirtz
金额:
$22.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-12-12 至 2015-11-30
关键词:
AcuteAdverse effectsAffectAntiviral AgentsB-LymphocytesBiochemicalBiological ModelsBone MarrowCell LineCellsChronicCoculture TechniquesDendritic CellsDevelopmentDiarrheaEngineeringEpithelial CellsFlagellinGeneticGoalsHealthHumanitiesImmuneInfectionInfectious AgentInterferon Type IInterferon Type IIInterferonsIntestinesLeftLeukocytesMediatingMediator of activation proteinModalityModelingMolecularMusNatural ImmunityOutcomePathway interactionsPlaguePolyomavirusPreventionProcessProductionRelative (related person)ResistanceRoleRotavirusRotavirus InfectionsSeriesSmall IntestinesSourceSystemT-LymphocyteTherapeuticToll-Like Receptor 5ViralVirusVirus DiseasesWorkadaptive immunitycell typecombatcytokineimmune activationin vivoinfluenzavirusnovelnovel strategiespreventprotective effectreceptorresponseweapons
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Viral infections cause and/or promote many of humanity's most intractable health problems. Most viral
infections can neither be prevented nor cured thus leaving a great need for novel strategies to combat
these infectious agents. This proposal seeks to help fill this chasm by investigating our startling recent
discovery of the existence of a novel potent innate immune antiviral mechanism. Specifically, using
murine rotavirus (RV) infection as a model of an acute diarrhea---inducing infection in young mice and a
chronic infection in immune---deficient mice, we recently made the unexpected observation that systemic
administration of bacterial flagellin could prevent or eliminate ongoing rotavirus infection. Flagellin's
antiviral action was independent of adaptive immunity and interferon (type I and II) while requiring
hemopoietic cell expression of both known flagellin receptors, toll---like receptor 5 (TLR5) and Nod---like
receptor C4 (NLRC4). Flagellin's blockade of rotavirus infection may be utilizing pathways that normally
mediate bacterial---viral competition/crosstalk or prove to be a purely engineered approach that does not
mimic a naturally occurring in vivo process. Regardless, that exogenously administered flagellin results
in rapid cure of chronic viral infections that would not otherwise be resolved by immune compromised
hosts suggests the possibility that this mechanism, if understood and harnessed, might provide new
weapons against some of the numerous viruses that continue to plague humanity. Thus, while
development of new modalities to treat rotavirus infection is one potential outcome of this project, the
primary overall goal of this proposal is to define the mechanism underlying flagellin's antiviral
action so it can be harnessed to develop novel strategies to treat a variety of viral infections. We
will employ a series of inter---related genetic, immunological and biochemical approaches to define the cell
type(s), soluble mediator(s) that cure and prevent RV infection and decipher their mode of action.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intestinal microbiota-mediated rotavirus vaccine failure
-
批准号:10586698
-
项目类别:
-
资助金额:$77.25万
-
财政年份:2022
-
负责人:Andrew T Gewirtz
-
依托单位:
Intestinal microbiota-mediated rotavirus vaccine failure
-
批准号:10707184
-
项目类别:
-
资助金额:$78.37万
-
财政年份:2022
-
负责人:Andrew T Gewirtz
-
依托单位:
Intestinal M Cells and Secretory IgA Response to Defined Gut Microbiota
-
批准号:8684523
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2014
-
负责人:Andrew T Gewirtz
-
依托单位:
Intestinal M Cells and Secretory IgA Response to Defined Gut Microbiota
-
批准号:8793099
-
项目类别:
-
资助金额:$19.09万
-
财政年份:2014
-
负责人:Andrew T Gewirtz
-
依托单位:
Flagellin-Induced Antiviral Activity
-
批准号:8785652
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2013
-
负责人:Andrew T Gewirtz
-
依托单位:
Deconstructing Inflammation and Altered Microbiota in Metabolic Syndrome
-
批准号:9194750
-
项目类别:
-
资助金额:$44.51万
-
财政年份:2013
-
负责人:Andrew T Gewirtz
-
依托单位:
Deconstructing Inflammation and Altered Microbiota in Metabolic Syndrome
-
批准号:8842835
-
项目类别:
-
资助金额:$1.87万
-
财政年份:2013
-
负责人:Andrew T Gewirtz
-
依托单位:
Deconstructing Inflammation and Altered Microbiota In Metabolic Syndrome
-
批准号:8891414
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2013
-
负责人:Andrew T Gewirtz
-
依托单位:
DECONSTRUCTING INFLAMMATION AND ALTERED MICROBIOTA IN METABOLIC SYNDROME
-
批准号:10542824
-
项目类别:
-
资助金额:$49.61万
-
财政年份:2013
-
负责人:Andrew T Gewirtz
-
依托单位:
Deconstructing Inflammation and Altered Microbiota In Metabolic Syndrome
-
批准号:8609941
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2013
-
负责人:Andrew T Gewirtz
-
依托单位:
Deconstructing Inflammation and Altered Microbiota in Metabolic Syndrome
-
批准号:9323386
-
项目类别:
-
资助金额:$44.51万
-
财政年份:2013
-
负责人:Andrew T Gewirtz
-
依托单位:
DECONSTRUCTING INFLAMMATION AND ALTERED MICROBIOTA IN METABOLIC SYNDROME
-
批准号:10323678
-
项目类别:
-
资助金额:$49.64万
-
财政年份:2013
-
负责人:Andrew T Gewirtz
-
依托单位:
Deconstructing Inflammation and Altered Microbiota In Metabolic Syndrome
-
批准号:8708067
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2013
-
负责人:Andrew T Gewirtz
-
依托单位:
Gut Inflammation from Emulsifier Perturbations of Microbiota-Host Interactions
-
批准号:8986401
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2010
-
负责人:Andrew T Gewirtz
-
依托单位:
Pathophysiology of TLR5KO Colitis
-
批准号:8208232
-
项目类别:
-
资助金额:$26.77万
-
财政年份:2010
-
负责人:Andrew T Gewirtz
-
依托单位:
Host-Microbiota-Diet Interactions in Metabolic Syndrome and IBD
-
批准号:10304198
-
项目类别:
-
资助金额:$52.28万
-
财政年份:2010
-
负责人:Andrew T Gewirtz
-
依托单位:
Host-Microbiota-Diet Interactions in Metabolic Syndrome and IBD
-
批准号:10077834
-
项目类别:
-
资助金额:$52.19万
-
财政年份:2010
-
负责人:Andrew T Gewirtz
-
依托单位:
Pathophysiology of TLR5KO Colitis
-
批准号:8410557
-
项目类别:
-
资助金额:$28.65万
-
财政年份:2010
-
负责人:Andrew T Gewirtz
-
依托单位:
Flagellin-Induced Gut Epithelial Chemokine Secretion
-
批准号:8011277
-
项目类别:
-
资助金额:$10.16万
-
财政年份:2010
-
负责人:Andrew T Gewirtz
-
依托单位:
Host-Microbiota-Diet Interactions in Metabolic Syndrome and IBD
-
批准号:10549288
-
项目类别:
-
资助金额:$52.28万
-
财政年份:2010
-
负责人:Andrew T Gewirtz
-
依托单位:
海外基金